Sadhna Nitro commences production of first Para Aminophenol (PAP) plant; stock skids ~1%

20 Jun 2022 , 03:12 PM

Sadhana Nitro Chem Limited informed that it has commenced production of its first Para Aminophenol (PAP) plant on June 7, 2022.

The company outlined that the first ten days went towards stabilizing the plant operations.

The company takes pride to announce that plant operations have stabilized as of June 17, 2022, and the company is now introducing the product into the India Pharmaceutical market, stated the company in its regulatory filing.

SNCL’s Para Aminophenol is created by the catalytic reduction of Nitrobenzene with hydrogen. This is just the second plant of its sort in the world.

Para Aminophenol is principally utilized in the production of Paracetamol, the world’s most popular pain reliever. It is also employed in various sectors such as aerospace, cosmetics, and pharmaceuticals.

The factory will produce aniline oil, ammonium sulphate, and other byproducts as part of the process. Sales of which will also commence shortly. The PAP plant is for both, domestic consumption as well as for exports.

The company has been awarded under the Production Linked Incentive Scheme of the Department of Pharmaceuticals, Government of India. As part of the Atmanirbhar Bharat initiative, this plant will reduce dependence on imports of Para Aminophenol, required for critical API, Paracetamol.

At around 3.16 PM, Sadhana Nitro Chem was trading at Rs119.05 down by Rs1 or 0.83% from its previous closing of Rs120.05 on the BSE. The scrip touched intraday high and low of Rs122.35 and Rs114.20 respectively.